Sangamo Therapeutics, Inc.
Pembelian

SGMO Last Correction before the rally

378
After Roche partnered with SGMO for the Tau Alzheimer program ,
BIIB was so in anger Sangamo didnt want to give them another chance ,
they dumped almost all their remaining SGMO shares .

BIIB dumped 11.4 M shares into OPEX week

Now the stock is going down.( Worse than expected earnings trigger )

There is a big buying opportunity around 0.60 $

Note: Goldman increased their positions 10X

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.